Clinical Trials Browser

Interventional × Neoplastic Cells, Circulating × 90 days × Clear all

Neoplastic Cells, Circulating, Pancreatic Neoplasms

NCT06067503 2026-04-13

Biomarkers to Detect Endocrine Therapy Resistance

Phase 2 Recruiting

8 enrolled

Breast

Breast Neoplasms, Neoplastic Cells, Circulating, Neoplasm Metastasis, Carcinoma, Lobular

NCT03960021 2026-03-27

ARFIM

Phase NA Terminated

20 enrolled 2 charts

Gastrointestinal

Colonic Neoplasms, Neoplastic Cells, Circulating, Neoplasms

NCT07418125 2026-02-18

GALIA

Phase NA Recruiting

130 enrolled

Breast

Breast Neoplasms, Neoplastic Cells, Circulating

NCT07398170 2026-02-09

BIOLIMEN-1

Phase NA Not yet recruiting

15 enrolled

CNS

Meningioma, Neoplastic Cells, Circulating, Neoplasm Recurrence, Local

NCT02072616 2026-02-06

CTC-Pancreas

Phase NA Completed

101 enrolled

Neoplastic Cells, Circulating

NCT05360290 2026-02-03

CTCNeoBC-E

Phase NA Recruiting

484 enrolled

Breast

Breast Neoplasms, Neoplastic Cells, Circulating

NCT05988970 2026-01-27

SLEEP_CTC

Phase NA Completed

27 enrolled

Thoracic

Lung Neoplasms, Neoplastic Cells, Circulating

NCT05560776 2026-01-26

OPTIMAL

Phase NA Active not recruiting

120 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplastic Cells, Circulating

Clinical Trials

EUPhORIC

Biomarkers to Detect Endocrine Therapy Resistance

ARFIM

GALIA

BIOLIMEN-1

CTC-Pancreas

CTCNeoBC-E

SLEEP_CTC

OPTIMAL